Clinical Trials
37 trialsTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
Alkagin Paste in the Prevention of Radiation Dermatitis
Sir Mortimer B. Davis - Jewish General Hospital
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy
Cedars-Sinai Medical Center
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
University of California, Irvine
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
Dana-Farber Cancer Institute
CD70-targeted immunoPET Imaging of Kidney Cancer
RenJi Hospital
PRIAM
The Netherlands Cancer Institute
ABACUS-2
Queen Mary University of London
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
NiKang Therapeutics, Inc.
CAPTIV-8
British Columbia Cancer Agency
TURANDORELA
The Netherlands Cancer Institute
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
University of California, Irvine
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts
Promontory Therapeutics Inc.
Non-Viral TCR Gene Therapy
National Institutes of Health Clinical Center (CC)
ANZUP2001
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer
Sheba Medical Center
Evaluation of Ocoxin-ViusidĀ® in Advanced or Metastatic Ovarian Epithelial Cancer
Catalysis SL
En-Bloc Resection of Bladder Tumors
Medipol University
Trial of NanoPac Focal Therapy for Prostate Cancer
NanOlogy, LLC
Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma
Tianjin Medical University Second Hospital
INDIGO
Herlev and Gentofte Hospital
AVANIRA3
Jiangsu Cancer Institute & Hospital
ANLOLA
Jiangsu Cancer Institute & Hospital
Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)
M.D. Anderson Cancer Center
A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)
Celldex Therapeutics
Trial of NanoPacĀ® Focal Therapy in Subjects With Prostate Cancer
NanOlogy, LLC
Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers
Belgian Gynaecological Oncology Group
A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer
Cedars-Sinai Medical Center
Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy
Novartis
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Dendreon
Study of WST11 in Patients With Localized Prostate Cancer
Steba Biotech S.A.
JASINT1
Pierre Fabre Medicament
Study Using WST11 in Patients With Localized Prostate Cancer
Steba Biotech S.A.
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
Eli Lilly and Company
Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer
Pharmacyclics LLC.